News
Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...
Agency will require a Limitation of Use section in the prescribing information of all extended-release ADHD stimulants ...
Labels of all extended-release stimulants indicated for ADHD -- including certain formulations of amphetamine and ...
The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...
32m
ScienceAlert on MSNNew Weight-Loss Drugs Under Scrutiny Amid Pancreas ConcernsTo date, almost 400 reports of acute pancreatitis have been received from people using GLP-1 drugs such as Mounjaro, Wegovy, ...
SHOPPING: Give your weight loss efforts a serious push with Hims, the weight loss program that is tailored to your unique ...
Weight loss drugs like Ozempic have gained a lot of popularity However these medications are not without side effects One ...
Pharma giants are sweating on the results of a federal government request for guidance on adding weight loss drugs to the ...
Delhi High Court asks DCGI to consult experts on weight-loss drug combinations, addressing concerns over safety and approval ...
FOX News on MSN15h
New weight loss medicine seen as an alternative to Ozempic, GLP-1 drugsOne of the largest theater chains in the US again files for bankruptcy Officials provide update on California fireworks ...
53m
Melton Times on MSNSlimming World consultant emphasizes lifestyle changes over weight loss drugs for lasting resultsWeight loss drugs can’t replace the power of group support for lasting weight loss, says local expert A Slimming World ...
Both Wegovy and Ozempic are semaglutide – a drug that first entered the US market in 2017 as a diabetes medication. It was ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results